In our cohort, HPV-driven HNSCC was primarily encountered in tumours originating from the oropharynx. HPV16 was the most frequently encountered genotype in our cohort. It is recommended that determination of HPV status be based on single testing with RNAISH or dual testing of p16INK4a IHC in conjunction with HPVDNA as an acceptable alternative in resource limited settings to improve patient stratification for treatment as well as clinical outcomes.
Sathasivam et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: